{"meshTags":["Female","Immunohistochemistry","Breast Diseases","Receptor, ErbB-2","Breast Neoplasms","Breast","Humans","Enzyme-Linked Immunosorbent Assay"],"meshMinor":["Female","Immunohistochemistry","Breast Diseases","Receptor, ErbB-2","Breast Neoplasms","Breast","Humans","Enzyme-Linked Immunosorbent Assay"],"genes":["HER2","neu","HER2","neu","HER2","neu","HER2","neu"],"organisms":["9606"],"publicationTypes":["Journal Article"],"abstract":"Serum level of soluble HER2/neu in patients with tumors characterized by high expression of this protein (2+/3+ according to immunohistochemical analysis) was significantly higher than in patients with low expression of HER2/neu and in women with benign diseases of the mammary glands. The level of HER2/neu in the serum decreased after removal of the primary tumor in the majority of patients.","title":"Soluble fragment of HER2/neu receptor in the serum of patients with breast cancer with different levels of this protein expression in the tumor.","pubmedId":"18214297"}